Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Preventeron is a nutraceutical combination product developed by Enactis Healthcare, primarily indicated for the management of 'leaky gut' or increased intestinal permeability. The formulation contains hyperimmune bovine colostrum and zinc citrate as its active components. Hyperimmune bovine colostrum is rich in immunoglobulins (specifically IgG, comprising 33-38% of the sachet formulation), growth factors, and antimicrobial peptides, which provide passive immunity and promote the repair of the intestinal mucosal barrier. Zinc citrate is included to support epithelial integrity and enhance immune function. The product is available in India in capsule and sachet forms and is marketed for gastrointestinal health and the restoration of intestinal barrier function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Preventeron.